-
1
-
-
0033775891
-
Physiological functions of thioredoxin and thioredoxin reductase
-
Arnér E.S., and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 267 (2000) 6102-6109
-
(2000)
Eur J Biochem
, vol.267
, pp. 6102-6109
-
-
Arnér, E.S.1
Holmgren, A.2
-
2
-
-
0034652113
-
Thioredoxin reductase
-
Mustacich D., and Powis G. Thioredoxin reductase. Biochem J 346 Pt 1 (2000) 1-8
-
(2000)
Biochem J
, vol.346
, Issue.PART 1
, pp. 1-8
-
-
Mustacich, D.1
Powis, G.2
-
3
-
-
0032898734
-
Cloning, sequencing and functional expression of a novel human thioredoxin reductase
-
Gasdaska P.Y., Berggren M.M., Berry M.J., and Powis G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 442 (1999) 105-111
-
(1999)
FEBS Lett
, vol.442
, pp. 105-111
-
-
Gasdaska, P.Y.1
Berggren, M.M.2
Berry, M.J.3
Powis, G.4
-
5
-
-
0033561016
-
Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization
-
Miranda-Vizuete A., Damdimopoulos A.E., Pedrajas J.R., Gustafsson J.A., and Spyrou G. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur J Biochem 261 (1999) 405-412
-
(1999)
Eur J Biochem
, vol.261
, pp. 405-412
-
-
Miranda-Vizuete, A.1
Damdimopoulos, A.E.2
Pedrajas, J.R.3
Gustafsson, J.A.4
Spyrou, G.5
-
7
-
-
0033609827
-
Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases
-
Sun Q.A., Wu Y., Zappacosta F., Jeang K.T., Lee B.J., Hatfield D.L., et al. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274 (1999) 24522-24530
-
(1999)
J Biol Chem
, vol.274
, pp. 24522-24530
-
-
Sun, Q.A.1
Wu, Y.2
Zappacosta, F.3
Jeang, K.T.4
Lee, B.J.5
Hatfield, D.L.6
-
8
-
-
0347600923
-
The mammalian testis-specific thioredoxin system
-
Miranda-Vizuete A., Sadek C.M., Jimenez A., Krause M., Sutovsky P., and Oko R. The mammalian testis-specific thioredoxin system. Antioxid Redox Signal 6 (2004) 25-40
-
(2004)
Antioxid Redox Signal
, vol.6
, pp. 25-40
-
-
Miranda-Vizuete, A.1
Sadek, C.M.2
Jimenez, A.3
Krause, M.4
Sutovsky, P.5
Oko, R.6
-
9
-
-
0030588144
-
Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue
-
Gasdaska J.R., Gasdaska P.Y., Gallegos A., and Powis G. Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 37 (1996) 257-259
-
(1996)
Genomics
, vol.37
, pp. 257-259
-
-
Gasdaska, J.R.1
Gasdaska, P.Y.2
Gallegos, A.3
Powis, G.4
-
10
-
-
0024059244
-
Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes
-
Rozell B., Holmgren A., and Hansson H.A. Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes. Eur J Cell Biol 46 (1988) 470-477
-
(1988)
Eur J Cell Biol
, vol.46
, pp. 470-477
-
-
Rozell, B.1
Holmgren, A.2
Hansson, H.A.3
-
11
-
-
0021810653
-
Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats
-
Rozell B., Hansson H.A., Luthman M., and Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 38 (1985) 79-86
-
(1985)
Eur J Cell Biol
, vol.38
, pp. 79-86
-
-
Rozell, B.1
Hansson, H.A.2
Luthman, M.3
Holmgren, A.4
-
12
-
-
0034194276
-
Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region
-
Rundlof A.K., Carlsten M., Giacobini M.M., and Arner E.S. Prominent expression of the selenoprotein thioredoxin reductase in the medullary rays of the rat kidney and thioredoxin reductase mRNA variants differing at the 5′ untranslated region. Biochem J 347 Pt 3 (2000) 661-668
-
(2000)
Biochem J
, vol.347
, Issue.PART 3
, pp. 661-668
-
-
Rundlof, A.K.1
Carlsten, M.2
Giacobini, M.M.3
Arner, E.S.4
-
13
-
-
0030020576
-
A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity
-
Tamura T., and Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 93 (1996) 1006-1011
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 1006-1011
-
-
Tamura, T.1
Stadtman, T.C.2
-
14
-
-
0030499036
-
Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia
-
Berggren M., Gallegos A., Gasdaska J.R., Gasdaska P.Y., Warneke J., and Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 16 (1996) 3459-3466
-
(1996)
Anticancer Res
, vol.16
, pp. 3459-3466
-
-
Berggren, M.1
Gallegos, A.2
Gasdaska, J.R.3
Gasdaska, P.Y.4
Warneke, J.5
Powis, G.6
-
15
-
-
0042807630
-
The thioredoxin-thioredoxin reductase system: over-expression in human cancer
-
Lincoln D.T., Ali Emadi E.M., Tonissen K.F., and Clarke F.M. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res 23 (2003) 2425-2433
-
(2003)
Anticancer Res
, vol.23
, pp. 2425-2433
-
-
Lincoln, D.T.1
Ali Emadi, E.M.2
Tonissen, K.F.3
Clarke, F.M.4
-
16
-
-
0035918571
-
Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma
-
Kahlos K., Soini Y., Saily M., Koistinen P., Kakko S., Paakko P., et al. Up-regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma. Int J Cancer 95 (2001) 198-204
-
(2001)
Int J Cancer
, vol.95
, pp. 198-204
-
-
Kahlos, K.1
Soini, Y.2
Saily, M.3
Koistinen, P.4
Kakko, S.5
Paakko, P.6
-
17
-
-
0032552946
-
Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells
-
Gladyshev V.N., Factor V.M., Housseau F., and Hatfield D.L. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 251 (1998) 488-493
-
(1998)
Biochem Biophys Res Commun
, vol.251
, pp. 488-493
-
-
Gladyshev, V.N.1
Factor, V.M.2
Housseau, F.3
Hatfield, D.L.4
-
18
-
-
0034901958
-
Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma
-
Soini Y., Kahlos K., Napankangas U., Kaarteenaho-Wiik R., Saily M., Koistinen P., et al. Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma. Clin Cancer Res 7 (2001) 1750-1757
-
(2001)
Clin Cancer Res
, vol.7
, pp. 1750-1757
-
-
Soini, Y.1
Kahlos, K.2
Napankangas, U.3
Kaarteenaho-Wiik, R.4
Saily, M.5
Koistinen, P.6
-
19
-
-
0347600941
-
Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events
-
Rundlof A.K., and Arner E.S. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events. Antioxid Redox Signal 6 (2004) 41-52
-
(2004)
Antioxid Redox Signal
, vol.6
, pp. 41-52
-
-
Rundlof, A.K.1
Arner, E.S.2
-
20
-
-
1642523633
-
Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma
-
Turunen N., Karihtala P., Mantyniemi A., Sormunen R., Holmgren A., Kinnula V.L., et al. Thioredoxin is associated with proliferation, p53 expression and negative estrogen and progesterone receptor status in breast carcinoma. Apmis 112 (2004) 123-132
-
(2004)
Apmis
, vol.112
, pp. 123-132
-
-
Turunen, N.1
Karihtala, P.2
Mantyniemi, A.3
Sormunen, R.4
Holmgren, A.5
Kinnula, V.L.6
-
21
-
-
0033544915
-
Thioredoxin-dependent redox regulation of p53-mediated p21 activation
-
Ueno M., Masutani H., Arai R.J., Yamauchi A., Hirota K., Sakai T., et al. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274 (1999) 35809-35815
-
(1999)
J Biol Chem
, vol.274
, pp. 35809-35815
-
-
Ueno, M.1
Masutani, H.2
Arai, R.J.3
Yamauchi, A.4
Hirota, K.5
Sakai, T.6
-
22
-
-
20544433877
-
Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity
-
Seemann S., and Hainaut P. Roles of thioredoxin reductase 1 and APE/Ref-1 in the control of basal p53 stability and activity. Oncogene 24 (2005) 3853-3863
-
(2005)
Oncogene
, vol.24
, pp. 3853-3863
-
-
Seemann, S.1
Hainaut, P.2
-
23
-
-
0344406086
-
Expression of antioxidant enzymes in astrocytic brain tumors
-
Haapasalo H., Kylaniemi M., Paunul N., Kinnula V.L., and Soini Y. Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol 13 (2003) 155-164
-
(2003)
Brain Pathol
, vol.13
, pp. 155-164
-
-
Haapasalo, H.1
Kylaniemi, M.2
Paunul, N.3
Kinnula, V.L.4
Soini, Y.5
-
24
-
-
0030731916
-
Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium
-
Gallegos A., Berggren M., Gasdaska J.R., and Powis G. Mechanisms of the regulation of thioredoxin reductase activity in cancer cells by the chemopreventive agent selenium. Cancer Res 57 (1997) 4965-4970
-
(1997)
Cancer Res
, vol.57
, pp. 4965-4970
-
-
Gallegos, A.1
Berggren, M.2
Gasdaska, J.R.3
Powis, G.4
-
25
-
-
0032848137
-
Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase
-
Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis 20 (1999) 1657-1666
-
(1999)
Carcinogenesis
, vol.20
, pp. 1657-1666
-
-
Ganther, H.E.1
-
26
-
-
19944426986
-
Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation
-
Nalvarte I., Damdimopoulos A.E., Nystom C., Nordman T., Miranda-Vizuete A., Olsson J.M., et al. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation. J Biol Chem 279 (2004) 54510-54517
-
(2004)
J Biol Chem
, vol.279
, pp. 54510-54517
-
-
Nalvarte, I.1
Damdimopoulos, A.E.2
Nystom, C.3
Nordman, T.4
Miranda-Vizuete, A.5
Olsson, J.M.6
-
27
-
-
1642625262
-
Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group
-
Clark L.C., Combs Jr. G.F., Turnbull B.W., Slate E.H., Chalker D.K., Chow J., et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276 (1996) 1957-1963
-
(1996)
JAMA
, vol.276
, pp. 1957-1963
-
-
Clark, L.C.1
Combs Jr., G.F.2
Turnbull, B.W.3
Slate, E.H.4
Chalker, D.K.5
Chow, J.6
-
28
-
-
33644655166
-
Antiglioma activity of 2,2′:6′2″-terpyridineplatinum(II) complexes in a rat model-effects on cellular redox metabolism
-
Ahmadi R., Urig S., Hartmann M., Helmke B.M., Koncarevic S., Allenberger B., et al. Antiglioma activity of 2,2′:6′2″-terpyridineplatinum(II) complexes in a rat model-effects on cellular redox metabolism. Free Radic Biol Med 40 (2006) 763-778
-
(2006)
Free Radic Biol Med
, vol.40
, pp. 763-778
-
-
Ahmadi, R.1
Urig, S.2
Hartmann, M.3
Helmke, B.M.4
Koncarevic, S.5
Allenberger, B.6
-
29
-
-
0037195158
-
Selenomethionine regulation of p53 by a ref1-dependent redox mechanism
-
Seo Y.R., Kelley M.R., and Smith M.L. Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA 99 (2002) 14548-14553
-
(2002)
Proc Natl Acad Sci USA
, vol.99
, pp. 14548-14553
-
-
Seo, Y.R.1
Kelley, M.R.2
Smith, M.L.3
-
30
-
-
0036604401
-
Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer
-
Mohler J.L., Morris T.L., Ford O.H., Alvey R.F., Sakamoto C., and Gregory C.W. Identification of differentially expressed genes associated with androgen-independent growth of prostate cancer. Prostate 51 (2002) 247-255
-
(2002)
Prostate
, vol.51
, pp. 247-255
-
-
Mohler, J.L.1
Morris, T.L.2
Ford, O.H.3
Alvey, R.F.4
Sakamoto, C.5
Gregory, C.W.6
-
31
-
-
27144473412
-
Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells
-
Gan L., Yang X.L., Liu Q., and Xu H.B. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells. J Cell Biochem 96 (2005) 653-664
-
(2005)
J Cell Biochem
, vol.96
, pp. 653-664
-
-
Gan, L.1
Yang, X.L.2
Liu, Q.3
Xu, H.B.4
-
32
-
-
33744958179
-
Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells
-
Yoo M.H., Xu X.M., Carlson B.A., Gladyshev V.N., and Hatfield D.L. Thioredoxin reductase 1 deficiency reverses tumor phenotype and tumorigenicity of lung carcinoma cells. J Biol Chem 281 (2006) 13005-13008
-
(2006)
J Biol Chem
, vol.281
, pp. 13005-13008
-
-
Yoo, M.H.1
Xu, X.M.2
Carlson, B.A.3
Gladyshev, V.N.4
Hatfield, D.L.5
-
33
-
-
0141676724
-
Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings
-
Lechner S., Muller-Ladner U., Neumann E., Spottl T., Schlottmann K., Ruschoff J., et al. Thioredoxin reductase 1 expression in colon cancer: discrepancy between in vitro and in vivo findings. Lab Invest 83 (2003) 1321-1331
-
(2003)
Lab Invest
, vol.83
, pp. 1321-1331
-
-
Lechner, S.1
Muller-Ladner, U.2
Neumann, E.3
Spottl, T.4
Schlottmann, K.5
Ruschoff, J.6
-
34
-
-
0035957325
-
Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems
-
Sun Q.A., Kirnarsky L., Sherman S., and Gladyshev V.N. Selenoprotein oxidoreductase with specificity for thioredoxin and glutathione systems. Proc Natl Acad Sci USA 98 (2001) 3673-3678
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 3673-3678
-
-
Sun, Q.A.1
Kirnarsky, L.2
Sherman, S.3
Gladyshev, V.N.4
-
35
-
-
22544451578
-
Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation
-
Su D., Novoselov S.V., Sun Q.A., Moustafa M.E., Zhou Y., Oko R., et al. Mammalian selenoprotein thioredoxin-glutathione reductase. Roles in disulfide bond formation and sperm maturation. J Biol Chem 280 (2005) 26491-26498
-
(2005)
J Biol Chem
, vol.280
, pp. 26491-26498
-
-
Su, D.1
Novoselov, S.V.2
Sun, Q.A.3
Moustafa, M.E.4
Zhou, Y.5
Oko, R.6
-
36
-
-
27644446853
-
Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase
-
Sun Q.A., Su D., Novoselov S.V., Carlson B.A., Hatfield D.L., and Gladyshev V.N. Reaction mechanism and regulation of mammalian thioredoxin/glutathione reductase. Biochemistry 44 (2005) 14528-14537
-
(2005)
Biochemistry
, vol.44
, pp. 14528-14537
-
-
Sun, Q.A.1
Su, D.2
Novoselov, S.V.3
Carlson, B.A.4
Hatfield, D.L.5
Gladyshev, V.N.6
-
37
-
-
0035793630
-
Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing
-
Sun Q.A., Zappacosta F., Factor V.M., Wirth P.J., Hatfield D.L., and Gladyshev V.N. Heterogeneity within animal thioredoxin reductases. Evidence for alternative first exon splicing. J Biol Chem 276 (2001) 3106-3114
-
(2001)
J Biol Chem
, vol.276
, pp. 3106-3114
-
-
Sun, Q.A.1
Zappacosta, F.2
Factor, V.M.3
Wirth, P.J.4
Hatfield, D.L.5
Gladyshev, V.N.6
-
38
-
-
1242338754
-
Evidence for intriguingly complex transcription of human thioredoxin reductase 1
-
Rundlof A.K., Janard M., Miranda-Vizuete A., and Arner E.S. Evidence for intriguingly complex transcription of human thioredoxin reductase 1. Free Radic Biol Med 36 (2004) 641-656
-
(2004)
Free Radic Biol Med
, vol.36
, pp. 641-656
-
-
Rundlof, A.K.1
Janard, M.2
Miranda-Vizuete, A.3
Arner, E.S.4
-
39
-
-
4644298932
-
Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1
-
Su D., and Gladyshev V.N. Alternative splicing involving the thioredoxin reductase module in mammals: a glutaredoxin-containing thioredoxin reductase 1. Biochemistry 43 (2004) 12177-12188
-
(2004)
Biochemistry
, vol.43
, pp. 12177-12188
-
-
Su, D.1
Gladyshev, V.N.2
-
40
-
-
4644313264
-
Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress
-
Smart D.K., Ortiz K.L., Mattson D., Bradbury C.M., Bisht K.S., Sieck L.K., et al. Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res 64 (2004) 6716-6724
-
(2004)
Cancer Res
, vol.64
, pp. 6716-6724
-
-
Smart, D.K.1
Ortiz, K.L.2
Mattson, D.3
Bradbury, C.M.4
Bisht, K.S.5
Sieck, L.K.6
-
41
-
-
0242277285
-
The thioredoxin system-from science to clinic
-
Gromer S., Urig S., and Becker K. The thioredoxin system-from science to clinic. Med Res Rev 24 (2004) 40-89
-
(2004)
Med Res Rev
, vol.24
, pp. 40-89
-
-
Gromer, S.1
Urig, S.2
Becker, K.3
-
42
-
-
0033781942
-
Thioredoxin reductase two modes of catalysis have evolved
-
Williams C.H., Arscott L.D., Muller S., Lennon B.W., Ludwig M.L., Wang P.F., et al. Thioredoxin reductase two modes of catalysis have evolved. Eur J Biochem 267 (2000) 6110-6117
-
(2000)
Eur J Biochem
, vol.267
, pp. 6110-6117
-
-
Williams, C.H.1
Arscott, L.D.2
Muller, S.3
Lennon, B.W.4
Ludwig, M.L.5
Wang, P.F.6
-
43
-
-
0030887844
-
The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli
-
Arscott L.D., Gromer S., Schirmer R.H., Becker K., and Williams Jr. C.H. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA 94 (1997) 3621-3626
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 3621-3626
-
-
Arscott, L.D.1
Gromer, S.2
Schirmer, R.H.3
Becker, K.4
Williams Jr., C.H.5
-
44
-
-
0034674566
-
Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations
-
Zhong L., and Holmgren A. Essential role of selenium in the catalytic activities of mammalian thioredoxin reductase revealed by characterization of recombinant enzymes with selenocysteine mutations. J Biol Chem 275 (2000) 18121-18128
-
(2000)
J Biol Chem
, vol.275
, pp. 18121-18128
-
-
Zhong, L.1
Holmgren, A.2
-
45
-
-
0032103493
-
A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase
-
Gromer S., Wissing J., Behne D., Ashman K., Schirmer R.H., Flohe L., et al. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J 332 Pt 2 (1998) 591-592
-
(1998)
Biochem J
, vol.332
, Issue.PART 2
, pp. 591-592
-
-
Gromer, S.1
Wissing, J.2
Behne, D.3
Ashman, K.4
Schirmer, R.H.5
Flohe, L.6
-
46
-
-
0033775650
-
Thioredoxin reductase as a pathophysiological factor and drug target
-
Becker K., Gromer S., Schirmer R.H., and Muller S. Thioredoxin reductase as a pathophysiological factor and drug target. Eur J Biochem 267 (2000) 6118-6125
-
(2000)
Eur J Biochem
, vol.267
, pp. 6118-6125
-
-
Becker, K.1
Gromer, S.2
Schirmer, R.H.3
Muller, S.4
-
47
-
-
0347908853
-
Disulfide reductases-current development
-
Chapman S., Perham R., and Scrutton N. (Eds), Rudolf Weber, Berlin p. 803-15
-
Irmler A., Bechthold A., Davioud-Charvet E., Hofmann V., Réau R., Gromer S., et al. Disulfide reductases-current development. In: Chapman S., Perham R., and Scrutton N. (Eds). Flavins and Flavoproteins (2002), Rudolf Weber, Berlin p. 803-15
-
(2002)
Flavins and Flavoproteins
-
-
Irmler, A.1
Bechthold, A.2
Davioud-Charvet, E.3
Hofmann, V.4
Réau, R.5
Gromer, S.6
-
48
-
-
33751175035
-
Platinum(II) complexes: inhibition of thioredoxin reductase in glioblastoma therapy
-
Nishino R.M.T., Tanokura T., and Fukui K. (Eds), ARchiTect Inc., Tokyo
-
Urig S., Ahmadi R., Herold-Mende C., Alber D., and Becker K. Platinum(II) complexes: inhibition of thioredoxin reductase in glioblastoma therapy. In: Nishino R.M.T., Tanokura T., and Fukui K. (Eds). Flavins and Flavoproteins (2005), ARchiTect Inc., Tokyo 877-882
-
(2005)
Flavins and Flavoproteins
, pp. 877-882
-
-
Urig, S.1
Ahmadi, R.2
Herold-Mende, C.3
Alber, D.4
Becker, K.5
-
49
-
-
0032502720
-
Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue
-
Zhong L., Arn-er E.S., Ljung J., Aslund F., and Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 273 (1998) 8581-8591
-
(1998)
J Biol Chem
, vol.273
, pp. 8581-8591
-
-
Zhong, L.1
Arn-er, E.S.2
Ljung, J.3
Aslund, F.4
Holmgren, A.5
-
50
-
-
0035859927
-
Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme
-
Sandalova T., Zhong L., Lindqvist Y., Holmgren A., and Schneider G. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme. Proc Natl Acad Sci USA 98 (2001) 9533-9538
-
(2001)
Proc Natl Acad Sci USA
, vol.98
, pp. 9533-9538
-
-
Sandalova, T.1
Zhong, L.2
Lindqvist, Y.3
Holmgren, A.4
Schneider, G.5
-
51
-
-
27244458231
-
Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism
-
Biterova E.I., Turanov A.A., Gladyshev V.N., and Barycki J.J. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism. Proc Natl Acad Sci USA 102 (2005) 15018-15023
-
(2005)
Proc Natl Acad Sci USA
, vol.102
, pp. 15018-15023
-
-
Biterova, E.I.1
Turanov, A.A.2
Gladyshev, V.N.3
Barycki, J.J.4
-
52
-
-
21144455675
-
The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: proposition of a swapping catalytic triad including a Sec-His-Glu state
-
Brandt W., and Wessjohann L.A. The functional role of selenocysteine (Sec) in the catalysis mechanism of large thioredoxin reductases: proposition of a swapping catalytic triad including a Sec-His-Glu state. Chembiochem 6 (2005) 386-394
-
(2005)
Chembiochem
, vol.6
, pp. 386-394
-
-
Brandt, W.1
Wessjohann, L.A.2
-
53
-
-
0029051872
-
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide
-
Yokomizo A., Ono M., Nanri H., Makino Y., Ohga T., Wada M., et al. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. Cancer Res 55 (1995) 4293-4296
-
(1995)
Cancer Res
, vol.55
, pp. 4293-4296
-
-
Yokomizo, A.1
Ono, M.2
Nanri, H.3
Makino, Y.4
Ohga, T.5
Wada, M.6
-
54
-
-
0036019932
-
Redox control of cell death
-
Ueda S., Masutani H., Nakamura H., Tanaka T., Ueno M., and Yodoi J. Redox control of cell death. Antioxid Redox Signal 4 (2002) 405-414
-
(2002)
Antioxid Redox Signal
, vol.4
, pp. 405-414
-
-
Ueda, S.1
Masutani, H.2
Nakamura, H.3
Tanaka, T.4
Ueno, M.5
Yodoi, J.6
-
55
-
-
6344277918
-
Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function
-
Conrad M., Jakupoglu C., Moreno S.G., Lippl S., Banjac A., Schneider M., et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 24 (2004) 9414-9423
-
(2004)
Mol Cell Biol
, vol.24
, pp. 9414-9423
-
-
Conrad, M.1
Jakupoglu, C.2
Moreno, S.G.3
Lippl, S.4
Banjac, A.5
Schneider, M.6
-
56
-
-
20044378664
-
Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development
-
Jakupoglu C., Przemeck G.K., Schneider M., Moreno S.G., Mayr N., Hatzopoulos A.K., et al. Cytoplasmic thioredoxin reductase is essential for embryogenesis but dispensable for cardiac development. Mol Cell Biol 25 (2005) 1980-1988
-
(2005)
Mol Cell Biol
, vol.25
, pp. 1980-1988
-
-
Jakupoglu, C.1
Przemeck, G.K.2
Schneider, M.3
Moreno, S.G.4
Mayr, N.5
Hatzopoulos, A.K.6
-
57
-
-
0141922903
-
Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds
-
Pallis M., Bradshaw T.D., Westwell A.D., Grundy M., Stevens M.F., and Russell N. Induction of apoptosis without redox catastrophe by thioredoxin-inhibitory compounds. Biochem Pharmacol 66 (2003) 1695-1705
-
(2003)
Biochem Pharmacol
, vol.66
, pp. 1695-1705
-
-
Pallis, M.1
Bradshaw, T.D.2
Westwell, A.D.3
Grundy, M.4
Stevens, M.F.5
Russell, N.6
-
58
-
-
0035397393
-
Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data
-
Cortes A., Cascante M., Cardenas M.L., and Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem J 357 (2001) 263-268
-
(2001)
Biochem J
, vol.357
, pp. 263-268
-
-
Cortes, A.1
Cascante, M.2
Cardenas, M.L.3
Cornish-Bowden, A.4
-
59
-
-
14944384045
-
Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes
-
Giovagnini L., Ronconi L., Aldinucci D., Lorenzon D., Sitran S., and Fregona D. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes. J Med Chem 48 (2005) 1588-1595
-
(2005)
J Med Chem
, vol.48
, pp. 1588-1595
-
-
Giovagnini, L.1
Ronconi, L.2
Aldinucci, D.3
Lorenzon, D.4
Sitran, S.5
Fregona, D.6
-
60
-
-
20144378947
-
Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase
-
Deponte M., Urig S., Arscott L.D., Fritz-Wolf K., Réau R., Herold-Mende C., et al. Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductase. J Biol Chem 280 (2005) 20628-20637
-
(2005)
J Biol Chem
, vol.280
, pp. 20628-20637
-
-
Deponte, M.1
Urig, S.2
Arscott, L.D.3
Fritz-Wolf, K.4
Réau, R.5
Herold-Mende, C.6
-
61
-
-
0036688034
-
Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative
-
Rigobello M.P., Scutari G., Boscolo R., and Bindoli A. Induction of mitochondrial permeability transition by auranofin, a gold(I)-phosphine derivative. Br J Pharmacol 136 (2002) 1162-1168
-
(2002)
Br J Pharmacol
, vol.136
, pp. 1162-1168
-
-
Rigobello, M.P.1
Scutari, G.2
Boscolo, R.3
Bindoli, A.4
-
62
-
-
5344266051
-
Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions
-
Rigobello M.P., Messori L., Marcon G., Cinellu M.A., Bragadin M., Folda A., et al. Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions. J Inorg Biochem 98 (2004) 1634-1641
-
(2004)
J Inorg Biochem
, vol.98
, pp. 1634-1641
-
-
Rigobello, M.P.1
Messori, L.2
Marcon, G.3
Cinellu, M.A.4
Bragadin, M.5
Folda, A.6
-
63
-
-
33645911782
-
Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase
-
Rigobello M.P., Vianello F., Folda A., Roman C., Scutari G., and Bindoli A. Differential effect of calcium ions on the cytosolic and mitochondrial thioredoxin reductase. Biochem Biophys Res Commun 343 (2006) 873-878
-
(2006)
Biochem Biophys Res Commun
, vol.343
, pp. 873-878
-
-
Rigobello, M.P.1
Vianello, F.2
Folda, A.3
Roman, C.4
Scutari, G.5
Bindoli, A.6
-
64
-
-
0031984162
-
Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability
-
Rigobello M.P., Callegaro M.T., Barzon E., Benetti M., and Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 24 (1998) 370-376
-
(1998)
Free Radic Biol Med
, vol.24
, pp. 370-376
-
-
Rigobello, M.P.1
Callegaro, M.T.2
Barzon, E.3
Benetti, M.4
Bindoli, A.5
-
65
-
-
0034705133
-
Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence
-
Zhong L., Arner E.S., and Holmgren A. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence. Proc Natl Acad Sci USA 97 (2000) 5854-5859
-
(2000)
Proc Natl Acad Sci USA
, vol.97
, pp. 5854-5859
-
-
Zhong, L.1
Arner, E.S.2
Holmgren, A.3
-
66
-
-
0032493647
-
Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds
-
Gromer S., Arscott L.D., Williams Jr. C.H., Schirmer R.H., and Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 273 (1998) 20096-20101
-
(1998)
J Biol Chem
, vol.273
, pp. 20096-20101
-
-
Gromer, S.1
Arscott, L.D.2
Williams Jr., C.H.3
Schirmer, R.H.4
Becker, K.5
-
67
-
-
0242300123
-
Active sites of thioredoxin reductases: why selenoproteins?
-
Gromer S., Johansson L., Bauer H., Arscott L.D., Rauch S., Ballou D.P., et al. Active sites of thioredoxin reductases: why selenoproteins?. Proc Natl Acad Sci USA 100 (2003) 12618-12623
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 12618-12623
-
-
Gromer, S.1
Johansson, L.2
Bauer, H.3
Arscott, L.D.4
Rauch, S.5
Ballou, D.P.6
-
68
-
-
0042858330
-
The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster
-
Bauer H., Massey V., Arscott L.D., Schirmer R.H., Ballou D.P., and Williams Jr. C.H. The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster. J Biol Chem 278 (2003) 33020-33028
-
(2003)
J Biol Chem
, vol.278
, pp. 33020-33028
-
-
Bauer, H.1
Massey, V.2
Arscott, L.D.3
Schirmer, R.H.4
Ballou, D.P.5
Williams Jr., C.H.6
-
69
-
-
0025062053
-
The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase
-
Schallreuter K.U., Gleason F.K., and Wood J.M. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1054 (1990) 14-20
-
(1990)
Biochim Biophys Acta
, vol.1054
, pp. 14-20
-
-
Schallreuter, K.U.1
Gleason, F.K.2
Wood, J.M.3
-
70
-
-
23444435104
-
Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds
-
Witte A.B., Anestal K., Jerremalm E., Ehrsson H., and Arner E.S. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds. Free Radic Biol Med 39 (2005) 696-703
-
(2005)
Free Radic Biol Med
, vol.39
, pp. 696-703
-
-
Witte, A.B.1
Anestal, K.2
Jerremalm, E.3
Ehrsson, H.4
Arner, E.S.5
-
72
-
-
0642274801
-
Current chemotherapy for glioblastoma
-
Parney I.F., and Chang S.M. Current chemotherapy for glioblastoma. Cancer J 9 (2003) 149-156
-
(2003)
Cancer J
, vol.9
, pp. 149-156
-
-
Parney, I.F.1
Chang, S.M.2
-
73
-
-
33746315912
-
Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases
-
Urig S., Fritz-Wolf K., Reau R., Herold-Mende C., Toth K., Davioud-Charvet E., et al. Undressing of phosphine gold(I) complexes as irreversible inhibitors of human disulfide reductases. Angew Chem Int Ed Engl 45 (2006) 1881-1886
-
(2006)
Angew Chem Int Ed Engl
, vol.45
, pp. 1881-1886
-
-
Urig, S.1
Fritz-Wolf, K.2
Reau, R.3
Herold-Mende, C.4
Toth, K.5
Davioud-Charvet, E.6
-
74
-
-
27244453860
-
The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria
-
Rigobello M.P., Folda A., Scutari G., and Bindoli A. The modulation of thiol redox state affects the production and metabolism of hydrogen peroxide by heart mitochondria. Arch Biochem Biophys 441 (2005) 112-122
-
(2005)
Arch Biochem Biophys
, vol.441
, pp. 112-122
-
-
Rigobello, M.P.1
Folda, A.2
Scutari, G.3
Bindoli, A.4
-
75
-
-
22044444840
-
Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase
-
Rigobello M.P., Folda A., Baldoin M.C., Scutari G., and Bindoli A. Effect of auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase. Free Radic Res 39 (2005) 687-695
-
(2005)
Free Radic Res
, vol.39
, pp. 687-695
-
-
Rigobello, M.P.1
Folda, A.2
Baldoin, M.C.3
Scutari, G.4
Bindoli, A.5
-
76
-
-
33745221410
-
Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1)
-
[Epub ahead of print]
-
Omata Y., Folan M., Shaw M., Messer R.L., Lockwood P.E., Hobbs D., et al. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Toxicol In Vitro (2006) [Epub ahead of print]
-
(2006)
Toxicol In Vitro
-
-
Omata, Y.1
Folan, M.2
Shaw, M.3
Messer, R.L.4
Lockwood, P.E.5
Hobbs, D.6
-
77
-
-
0037061638
-
Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties
-
Marcon G., Carotti S., Coronnello M., Messori L., Mini E., Orioli P., et al. Gold(III) complexes with bipyridyl ligands: solution chemistry, cytotoxicity, and DNA binding properties. J Med Chem 45 (2002) 1672-1677
-
(2002)
J Med Chem
, vol.45
, pp. 1672-1677
-
-
Marcon, G.1
Carotti, S.2
Coronnello, M.3
Messori, L.4
Mini, E.5
Orioli, P.6
-
78
-
-
7444240714
-
Solution chemistry and cytotoxic properties of novel organogold(III) compounds
-
Messori L., Marcon G., Cinellu M.A., Coronnello M., Mini E., Gabbiani C., et al. Solution chemistry and cytotoxic properties of novel organogold(III) compounds. Bioorg Med Chem 12 (2004) 6039-6043
-
(2004)
Bioorg Med Chem
, vol.12
, pp. 6039-6043
-
-
Messori, L.1
Marcon, G.2
Cinellu, M.A.3
Coronnello, M.4
Mini, E.5
Gabbiani, C.6
-
79
-
-
33644855554
-
Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties
-
Ronconi L., Marzano C., Zanello P., Corsini M., Miolo G., Macca C., et al. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties. J Med Chem 49 (2006) 1648-1657
-
(2006)
J Med Chem
, vol.49
, pp. 1648-1657
-
-
Ronconi, L.1
Marzano, C.2
Zanello, P.3
Corsini, M.4
Miolo, G.5
Macca, C.6
-
80
-
-
27144548880
-
Mechanisms of cytotoxicity of selected organogold(III) compounds
-
Coronnello M., Mini E., Caciagli B., Cinellu M.A., Bindoli A., Gabbiani C., et al. Mechanisms of cytotoxicity of selected organogold(III) compounds. J Med Chem 48 (2005) 6761-6765
-
(2005)
J Med Chem
, vol.48
, pp. 6761-6765
-
-
Coronnello, M.1
Mini, E.2
Caciagli, B.3
Cinellu, M.A.4
Bindoli, A.5
Gabbiani, C.6
-
81
-
-
18244379333
-
Cellular processing of platinum anticancer drugs
-
Wang D., and Lippard S.J. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4 (2005) 307-320
-
(2005)
Nat Rev Drug Discov
, vol.4
, pp. 307-320
-
-
Wang, D.1
Lippard, S.J.2
-
82
-
-
22144441320
-
Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?
-
Zorbas H., and Keppler B.K. Cisplatin damage: are DNA repair proteins saviors or traitors to the cell?. Chembiochem 6 (2005) 1157-1166
-
(2005)
Chembiochem
, vol.6
, pp. 1157-1166
-
-
Zorbas, H.1
Keppler, B.K.2
-
83
-
-
0037430544
-
Interaction of binuclear xylylthiolato(2,2′,2″-terpyridine)platinum(II) complexes with DNA
-
Kurosaki H., Yamakawa N., Sumimoto M., Kimura K., and Goto M. Interaction of binuclear xylylthiolato(2,2′,2″-terpyridine)platinum(II) complexes with DNA. Bioorg Med Chem Lett 13 (2003) 825-828
-
(2003)
Bioorg Med Chem Lett
, vol.13
, pp. 825-828
-
-
Kurosaki, H.1
Yamakawa, N.2
Sumimoto, M.3
Kimura, K.4
Goto, M.5
-
84
-
-
27444435579
-
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors
-
Millet R., Urig S., Jacob J., Amtmann E., Moulinoux J.P., Gromer S., et al. Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitors. J Med Chem 48 (2005) 7024-7039
-
(2005)
J Med Chem
, vol.48
, pp. 7024-7039
-
-
Millet, R.1
Urig, S.2
Jacob, J.3
Amtmann, E.4
Moulinoux, J.P.5
Gromer, S.6
-
85
-
-
0035899183
-
Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2″- terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy
-
Becker K., Herold-Mende C., Park J.J., Lowe G., and Schirmer R.H. Human thioredoxin reductase is efficiently inhibited by (2,2′:6′,2″- terpyridine)platinum(II) complexes. Possible implications for a novel antitumor strategy. J Med Chem 44 (2001) 2784-2792
-
(2001)
J Med Chem
, vol.44
, pp. 2784-2792
-
-
Becker, K.1
Herold-Mende, C.2
Park, J.J.3
Lowe, G.4
Schirmer, R.H.5
-
86
-
-
0037188214
-
Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs
-
Jansen B.A., Brouwer J., and Reedijk J. Glutathione induces cellular resistance against cationic dinuclear platinum anticancer drugs. J Inorg Biochem 89 (2002) 197-202
-
(2002)
J Inorg Biochem
, vol.89
, pp. 197-202
-
-
Jansen, B.A.1
Brouwer, J.2
Reedijk, J.3
-
87
-
-
0030695172
-
Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo
-
Baker A., Payne C.M., Briehl M.M., and Powis G. Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. Cancer Res 57 (1997) 5162-5167
-
(1997)
Cancer Res
, vol.57
, pp. 5162-5167
-
-
Baker, A.1
Payne, C.M.2
Briehl, M.M.3
Powis, G.4
-
89
-
-
0346398299
-
Double-drug development against antioxidant enzymes from Plasmodium falciparum
-
Biot C., Dessolin J., Grellier P., and Davioud-Charvet E. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Redox Rep 8 (2003) 280-283
-
(2003)
Redox Rep
, vol.8
, pp. 280-283
-
-
Biot, C.1
Dessolin, J.2
Grellier, P.3
Davioud-Charvet, E.4
-
90
-
-
0034351135
-
Transfer of 4′-chloro-2,2′:6′,2″-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells
-
Ross S.A., Carr C.A., Briet J.W., and Lowe G. Transfer of 4′-chloro-2,2′:6′,2″-terpyridine platinum(II) between human serum albumin, glutathione and other thiolate ligands. A possible selective natural transport mechanism for the delivery of platinum(II) drugs to tumour cells. Anticancer Drug Des 15 (2000) 431-439
-
(2000)
Anticancer Drug Des
, vol.15
, pp. 431-439
-
-
Ross, S.A.1
Carr, C.A.2
Briet, J.W.3
Lowe, G.4
-
91
-
-
0023190095
-
New cisplatin analogies-on the way to better antitumor agents
-
Pasini A., and Zunino F. New cisplatin analogies-on the way to better antitumor agents. Angew Chem Int Ed Engl 26 (1987) 615-624
-
(1987)
Angew Chem Int Ed Engl
, vol.26
, pp. 615-624
-
-
Pasini, A.1
Zunino, F.2
-
92
-
-
22244452610
-
Novel platinum(IV) complexes induce rapid tumor cell death in vitro
-
Kaludjerovic G.N., Miljkovic D., Momcilovic M., Djinovic V.M., Stojkovic M.M., Sabo T.J., et al. Novel platinum(IV) complexes induce rapid tumor cell death in vitro. Int J Cancer 116 (2005) 479-486
-
(2005)
Int J Cancer
, vol.116
, pp. 479-486
-
-
Kaludjerovic, G.N.1
Miljkovic, D.2
Momcilovic, M.3
Djinovic, V.M.4
Stojkovic, M.M.5
Sabo, T.J.6
-
93
-
-
0141811013
-
Recent developments in the field of tumor-inhibiting metal complexes
-
Galanski M., Arion V.B., Jakupec M.A., and Keppler B.K. Recent developments in the field of tumor-inhibiting metal complexes. Curr Pharm Des 9 (2003) 2078-2089
-
(2003)
Curr Pharm Des
, vol.9
, pp. 2078-2089
-
-
Galanski, M.1
Arion, V.B.2
Jakupec, M.A.3
Keppler, B.K.4
-
94
-
-
0034040527
-
An update on satraplatin: the first orally available platinum anticancer drug
-
Kelland L.R. An update on satraplatin: the first orally available platinum anticancer drug. Expert Opin Investig Drugs 9 (2000) 1373-1382
-
(2000)
Expert Opin Investig Drugs
, vol.9
, pp. 1373-1382
-
-
Kelland, L.R.1
-
95
-
-
33744986491
-
The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours
-
[Epub ahead of print]
-
Hall M.D., Alderden R.A., Zhang M., Beale P.J., Cai Z., Lai B., et al. The fate of platinum(II) and platinum(IV) anti-cancer agents in cancer cells and tumours. J Struct Biol (2006) [Epub ahead of print]
-
(2006)
J Struct Biol
-
-
Hall, M.D.1
Alderden, R.A.2
Zhang, M.3
Beale, P.J.4
Cai, Z.5
Lai, B.6
-
96
-
-
24944503564
-
The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes
-
Mellor H.R., Snelling S., Hall M.D., Modok S., Jaffar M., Hambley T.W., et al. The influence of tumour microenvironmental factors on the efficacy of cisplatin and novel platinum(IV) complexes. Biochem Pharmacol 70 (2005) 1137-1146
-
(2005)
Biochem Pharmacol
, vol.70
, pp. 1137-1146
-
-
Mellor, H.R.1
Snelling, S.2
Hall, M.D.3
Modok, S.4
Jaffar, M.5
Hambley, T.W.6
-
97
-
-
5344277511
-
The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines
-
Hall M.D., Amjadi S., Zhang M., Beale P.J., and Hambley T.W. The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines. J Inorg Biochem 98 (2004) 1614-1624
-
(2004)
J Inorg Biochem
, vol.98
, pp. 1614-1624
-
-
Hall, M.D.1
Amjadi, S.2
Zhang, M.3
Beale, P.J.4
Hambley, T.W.5
-
100
-
-
0037366133
-
Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance
-
Fuertes M.A., Alonso C., and Perez J.M. Biochemical modulation of Cisplatin mechanisms of action: enhancement of antitumor activity and circumvention of drug resistance. Chem Rev 103 (2003) 645-662
-
(2003)
Chem Rev
, vol.103
, pp. 645-662
-
-
Fuertes, M.A.1
Alonso, C.2
Perez, J.M.3
-
101
-
-
0022858683
-
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs
-
Matsumura Y., and Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46 (1986) 6387-6392
-
(1986)
Cancer Res
, vol.46
, pp. 6387-6392
-
-
Matsumura, Y.1
Maeda, H.2
-
102
-
-
0026787767
-
Cisplatin-albumin complex for treatment of cancer of the head and neck
-
Vreeburg G.C., Stell P.M., Holding J.D., and Lindup W.E. Cisplatin-albumin complex for treatment of cancer of the head and neck. J Laryngol Otol 106 (1992) 832-833
-
(1992)
J Laryngol Otol
, vol.106
, pp. 832-833
-
-
Vreeburg, G.C.1
Stell, P.M.2
Holding, J.D.3
Lindup, W.E.4
-
103
-
-
0034447210
-
Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells
-
Engman L., Kandra T., Gallegos A., Williams R., and Powis G. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Anticancer Drug Des 15 (2000) 323-330
-
(2000)
Anticancer Drug Des
, vol.15
, pp. 323-330
-
-
Engman, L.1
Kandra, T.2
Gallegos, A.3
Williams, R.4
Powis, G.5
-
104
-
-
0037331676
-
Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants
-
Engman L., Al-Maharik N., McNaughton M., Birmingham A., and Powis G. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Anticancer Drugs 14 (2003) 153-161
-
(2003)
Anticancer Drugs
, vol.14
, pp. 153-161
-
-
Engman, L.1
Al-Maharik, N.2
McNaughton, M.3
Birmingham, A.4
Powis, G.5
-
105
-
-
0242361208
-
Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells
-
Engman L., Al-Maharik N., McNaughton M., Birmingham A., and Powis G. Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells. Bioorg Med Chem 11 (2003) 5091-5100
-
(2003)
Bioorg Med Chem
, vol.11
, pp. 5091-5100
-
-
Engman, L.1
Al-Maharik, N.2
McNaughton, M.3
Birmingham, A.4
Powis, G.5
-
106
-
-
0346731228
-
Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth
-
McNaughton M., Engman L., Birmingham A., Powis G., and Cotgreave I.A. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth. J Med Chem 47 (2004) 233-239
-
(2004)
J Med Chem
, vol.47
, pp. 233-239
-
-
McNaughton, M.1
Engman, L.2
Birmingham, A.3
Powis, G.4
Cotgreave, I.A.5
-
107
-
-
0041829414
-
A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines
-
Shi C., Yu L., Yang F., Yan J., and Zeng H. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Biochem Biophys Res Commun 309 (2003) 578-583
-
(2003)
Biochem Biophys Res Commun
, vol.309
, pp. 578-583
-
-
Shi, C.1
Yu, L.2
Yang, F.3
Yan, J.4
Zeng, H.5
-
108
-
-
33646097218
-
A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines
-
Zhao F., Yan J., Deng S., Lan L., He F., Kuang B., et al. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines. Cancer Lett 236 (2006) 46-53
-
(2006)
Cancer Lett
, vol.236
, pp. 46-53
-
-
Zhao, F.1
Yan, J.2
Deng, S.3
Lan, L.4
He, F.5
Kuang, B.6
-
109
-
-
0028955626
-
1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity
-
Arnér E.S., Bjornstedt M., and Holmgren A. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J Biol Chem 270 (1995) 3479-3482
-
(1995)
J Biol Chem
, vol.270
, pp. 3479-3482
-
-
Arnér, E.S.1
Bjornstedt, M.2
Holmgren, A.3
-
110
-
-
0032080238
-
Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue
-
Nordberg J., Zhong L., Holmgren A., and Arner E.S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 273 (1998) 10835-10842
-
(1998)
J Biol Chem
, vol.273
, pp. 10835-10842
-
-
Nordberg, J.1
Zhong, L.2
Holmgren, A.3
Arner, E.S.4
-
111
-
-
0035584857
-
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system
-
Nordberg J., and Arner E.S. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radic Biol Med 31 (2001) 1287-1312
-
(2001)
Free Radic Biol Med
, vol.31
, pp. 1287-1312
-
-
Nordberg, J.1
Arner, E.S.2
-
112
-
-
0032693662
-
Superoxide production by dinitrophenyl-derivatized thioredoxin reductase-a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes
-
Arnér E.S. Superoxide production by dinitrophenyl-derivatized thioredoxin reductase-a model for the mechanism and correlation to immunostimulation by dinitrohalobenzenes. Biofactors 10 (1999) 219-226
-
(1999)
Biofactors
, vol.10
, pp. 219-226
-
-
Arnér, E.S.1
-
113
-
-
33646806762
-
Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells
-
Cenas N., Prast S., Nivinskas H., Sarlauskas J., and Arner E.S. Interactions of nitroaromatic compounds with the mammalian selenoprotein thioredoxin reductase and the relation to induction of apoptosis in human cancer cells. J Biol Chem 281 (2006) 5593-5603
-
(2006)
J Biol Chem
, vol.281
, pp. 5593-5603
-
-
Cenas, N.1
Prast, S.2
Nivinskas, H.3
Sarlauskas, J.4
Arner, E.S.5
-
114
-
-
1642535437
-
Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein
-
Cenas N., Nivinskas H., Anusevicius Z., Sarlauskas J., Lederer F., and Arner E.S. Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein. J Biol Chem 279 (2004) 2583-2592
-
(2004)
J Biol Chem
, vol.279
, pp. 2583-2592
-
-
Cenas, N.1
Nivinskas, H.2
Anusevicius, Z.3
Sarlauskas, J.4
Lederer, F.5
Arner, E.S.6
-
115
-
-
21644477778
-
Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity
-
Fang J., Lu J., and Holmgren A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J Biol Chem (2005)
-
(2005)
J Biol Chem
-
-
Fang, J.1
Lu, J.2
Holmgren, A.3
-
116
-
-
33646233781
-
Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity
-
Lu J., Papp L.V., Fang J., Rodriguez-Nieto S., Zhivotovsky B., and Holmgren A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res 66 (2006) 4410-4418
-
(2006)
Cancer Res
, vol.66
, pp. 4410-4418
-
-
Lu, J.1
Papp, L.V.2
Fang, J.3
Rodriguez-Nieto, S.4
Zhivotovsky, B.5
Holmgren, A.6
-
117
-
-
33744956073
-
Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase
-
Hashemy S.I., Ungerstedt J.S., Avval F.Z., and Holmgren A. Motexafin gadolinium, a tumor-selective drug targeting thioredoxin reductase and ribonucleotide reductase. J Biol Chem 281 (2006) 10691-10697
-
(2006)
J Biol Chem
, vol.281
, pp. 10691-10697
-
-
Hashemy, S.I.1
Ungerstedt, J.S.2
Avval, F.Z.3
Holmgren, A.4
-
118
-
-
0034683041
-
First crystal structure of a medicinally relevant gold protein complex: unexpected binding of
-
Zou J., Taylor P., Dornan J., Robinson S.P., Walkinshaw M.D., and Sadler P.J. First crystal structure of a medicinally relevant gold protein complex: unexpected binding of. Angew Chem Int Ed Engl 39 (2000) 2931-2934
-
(2000)
Angew Chem Int Ed Engl
, vol.39
, pp. 2931-2934
-
-
Zou, J.1
Taylor, P.2
Dornan, J.3
Robinson, S.P.4
Walkinshaw, M.D.5
Sadler, P.J.6
-
120
-
-
33748135586
-
Glioblastoma multiforme: mechanisms of resistance to chemotherapy
-
Rieger J., Roth W., Glaser T., Winter S., Rieger L., Dichgans J., et al. Glioblastoma multiforme: mechanisms of resistance to chemotherapy. Neurol Psych Brain Res 7 (1999) 37-46
-
(1999)
Neurol Psych Brain Res
, vol.7
, pp. 37-46
-
-
Rieger, J.1
Roth, W.2
Glaser, T.3
Winter, S.4
Rieger, L.5
Dichgans, J.6
-
121
-
-
1242331014
-
Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system
-
Jonsson-Videsater K., Bjorkhem-Bergman L., Hossain A., Soderberg A., Eriksson L.C., Paul C., et al. Selenite-induced apoptosis in doxorubicin-resistant cells and effects on the thioredoxin system. Biochem Pharmacol 67 (2004) 513-522
-
(2004)
Biochem Pharmacol
, vol.67
, pp. 513-522
-
-
Jonsson-Videsater, K.1
Bjorkhem-Bergman, L.2
Hossain, A.3
Soderberg, A.4
Eriksson, L.C.5
Paul, C.6
-
122
-
-
0346252644
-
Novel chemotherapeutic agents for the treatment of glioblastoma multiforme
-
Jendrossek V., Belka C., and Bamberg M. Novel chemotherapeutic agents for the treatment of glioblastoma multiforme. Expert Opin Investig Drugs 12 (2003) 1899-1924
-
(2003)
Expert Opin Investig Drugs
, vol.12
, pp. 1899-1924
-
-
Jendrossek, V.1
Belka, C.2
Bamberg, M.3
-
123
-
-
0032840612
-
Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum(II)
-
Sasada T., Nakamura H., Ueda S., Sato N., Kitaoka Y., Gon Y., et al. Possible involvement of thioredoxin reductase as well as thioredoxin in cellular sensitivity to cis-diamminedichloroplatinum(II). Free Radic Biol Med 27 (1999) 504-514
-
(1999)
Free Radic Biol Med
, vol.27
, pp. 504-514
-
-
Sasada, T.1
Nakamura, H.2
Ueda, S.3
Sato, N.4
Kitaoka, Y.5
Gon, Y.6
-
124
-
-
0037082122
-
Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species
-
Senturker S., Tschirret-Guth R., Morrow J., Levine R., and Shacter E. Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species. Arch Biochem Biophys 397 (2002) 262-272
-
(2002)
Arch Biochem Biophys
, vol.397
, pp. 262-272
-
-
Senturker, S.1
Tschirret-Guth, R.2
Morrow, J.3
Levine, R.4
Shacter, E.5
-
125
-
-
14044273000
-
Antiapoptotic response to induced GSH depletion: involvement of heat shock proteins and NF-kappaB activation
-
Filomeni G., Aquilano K., Rotilio G., and Ciriolo M.R. Antiapoptotic response to induced GSH depletion: involvement of heat shock proteins and NF-kappaB activation. Antioxid Redox Signal 7 (2005) 446-455
-
(2005)
Antioxid Redox Signal
, vol.7
, pp. 446-455
-
-
Filomeni, G.1
Aquilano, K.2
Rotilio, G.3
Ciriolo, M.R.4
-
126
-
-
2442464889
-
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
-
Pommier Y., Sordet O., Antony S., Hayward R.L., and Kohn K.W. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 23 (2004) 2934-2949
-
(2004)
Oncogene
, vol.23
, pp. 2934-2949
-
-
Pommier, Y.1
Sordet, O.2
Antony, S.3
Hayward, R.L.4
Kohn, K.W.5
-
127
-
-
2442689078
-
Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo
-
Sullivan A., Syed N., Gasco M., Bergamaschi D., Trigiante G., Attard M., et al. Polymorphism in wild-type p53 modulates response to chemotherapy in vitro and in vivo. Oncogene 23 (2004) 3328-3337
-
(2004)
Oncogene
, vol.23
, pp. 3328-3337
-
-
Sullivan, A.1
Syed, N.2
Gasco, M.3
Bergamaschi, D.4
Trigiante, G.5
Attard, M.6
-
128
-
-
0028568427
-
The role of the p53 and Rb-1 genes in cancer, development and apoptosis
-
Hooper M.L. The role of the p53 and Rb-1 genes in cancer, development and apoptosis. J Cell Sci Suppl 18 (1994) 13-17
-
(1994)
J Cell Sci Suppl
, vol.18
, pp. 13-17
-
-
Hooper, M.L.1
-
129
-
-
0036635227
-
Prognostic relevance of p53 protein expression in glioblastoma
-
Birner P., Piribauer M., Fischer I., Gatterbauer B., Marosi C., Ungersbock K., et al. Prognostic relevance of p53 protein expression in glioblastoma. Oncol Rep 9 (2002) 703-707
-
(2002)
Oncol Rep
, vol.9
, pp. 703-707
-
-
Birner, P.1
Piribauer, M.2
Fischer, I.3
Gatterbauer, B.4
Marosi, C.5
Ungersbock, K.6
-
130
-
-
0033864687
-
A new resistance mechanism to cisplatin?
-
Kelland L.R. A new resistance mechanism to cisplatin?. Drug Resist Updat 3 (2000) 139-141
-
(2000)
Drug Resist Updat
, vol.3
, pp. 139-141
-
-
Kelland, L.R.1
-
131
-
-
1542787935
-
Intracavitary chemotherapy for glioblastoma: present status and future directions
-
Westphal M., Lamszus K., and Hilt D. Intracavitary chemotherapy for glioblastoma: present status and future directions. Acta Neurochir Suppl 88 (2003) 61-67
-
(2003)
Acta Neurochir Suppl
, vol.88
, pp. 61-67
-
-
Westphal, M.1
Lamszus, K.2
Hilt, D.3
-
132
-
-
3042848683
-
Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells
-
Jeremias I., Steiner H.H., Benner A., Debatin K.M., and Herold-Mende C. Cell death induction by betulinic acid, ceramide and TRAIL in primary glioblastoma multiforme cells. Acta Neurochir (Wien) 146 (2004) 721-729
-
(2004)
Acta Neurochir (Wien)
, vol.146
, pp. 721-729
-
-
Jeremias, I.1
Steiner, H.H.2
Benner, A.3
Debatin, K.M.4
Herold-Mende, C.5
-
133
-
-
0033572413
-
Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11
-
Gliniak B., and Le T. Tumor necrosis factor-related apoptosis-inducing ligand's antitumor activity in vivo is enhanced by the chemotherapeutic agent CPT-11. Cancer Res 59 (1999) 6153-6158
-
(1999)
Cancer Res
, vol.59
, pp. 6153-6158
-
-
Gliniak, B.1
Le, T.2
-
134
-
-
0034652486
-
Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
-
Nagane M., Pan G., Weddle J.J., Dixit V.M., Cavenee W.K., and Huang H.J. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo. Cancer Res 60 (2000) 847-853
-
(2000)
Cancer Res
, vol.60
, pp. 847-853
-
-
Nagane, M.1
Pan, G.2
Weddle, J.J.3
Dixit, V.M.4
Cavenee, W.K.5
Huang, H.J.6
-
135
-
-
0034812659
-
Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety
-
Kelley S.K., Harris L.A., Xie D., Deforge L., Totpal K., Bussiere J., et al. Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety. J Pharmacol Exp Ther 299 (2001) 31-38
-
(2001)
J Pharmacol Exp Ther
, vol.299
, pp. 31-38
-
-
Kelley, S.K.1
Harris, L.A.2
Xie, D.3
Deforge, L.4
Totpal, K.5
Bussiere, J.6
-
136
-
-
0036341291
-
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo
-
Fulda S., Wick W., Weller M., and Debatin K.M. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8 (2002) 808-815
-
(2002)
Nat Med
, vol.8
, pp. 808-815
-
-
Fulda, S.1
Wick, W.2
Weller, M.3
Debatin, K.M.4
-
137
-
-
0036215245
-
TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells
-
Beltinger C., Fulda S., Walczak H., and Debatin K.M. TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells. Cancer Gene Ther 9 (2002) 372-381
-
(2002)
Cancer Gene Ther
, vol.9
, pp. 372-381
-
-
Beltinger, C.1
Fulda, S.2
Walczak, H.3
Debatin, K.M.4
-
139
-
-
0026655577
-
Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents
-
Britten R.A., Green J.A., and Warenius H.M. Cellular glutathione (GSH) and glutathione S-transferase (GST) activity in human ovarian tumor biopsies following exposure to alkylating agents. Int J Radiat Oncol Biol Phys 24 (1992) 527-531
-
(1992)
Int J Radiat Oncol Biol Phys
, vol.24
, pp. 527-531
-
-
Britten, R.A.1
Green, J.A.2
Warenius, H.M.3
-
140
-
-
0034306344
-
Glutathione S-transferase and drug sensitivity in malignant glioma
-
Winter S., Strik H., Rieger J., Beck J., Meyermann R., and Weller M. Glutathione S-transferase and drug sensitivity in malignant glioma. J Neurol Sci 179 (2000) 115-121
-
(2000)
J Neurol Sci
, vol.179
, pp. 115-121
-
-
Winter, S.1
Strik, H.2
Rieger, J.3
Beck, J.4
Meyermann, R.5
Weller, M.6
-
141
-
-
0026459859
-
The ATP-dependent glutathione S-conjugate export pump
-
Ishikawa T. The ATP-dependent glutathione S-conjugate export pump. Trends Biochem Sci 17 (1992) 463-468
-
(1992)
Trends Biochem Sci
, vol.17
, pp. 463-468
-
-
Ishikawa, T.1
-
142
-
-
4344625883
-
A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells
-
Friesen C., Kiess Y., and Debatin K.M. A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Cell Death Differ 11 (2004) S73-S85
-
(2004)
Cell Death Differ
, vol.11
-
-
Friesen, C.1
Kiess, Y.2
Debatin, K.M.3
-
143
-
-
0022537052
-
Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs
-
Russo A., DeGraff W., Friedman N., and Mitchell J.B. Selective modulation of glutathione levels in human normal versus tumor cells and subsequent differential response to chemotherapy drugs. Cancer Res 46 (1986) 2845-2848
-
(1986)
Cancer Res
, vol.46
, pp. 2845-2848
-
-
Russo, A.1
DeGraff, W.2
Friedman, N.3
Mitchell, J.B.4
-
144
-
-
4243524912
-
Potential for selective modulation of glutathione in cancer chemotherapy
-
Chen X., Carystinos G.D., and Batist G. Potential for selective modulation of glutathione in cancer chemotherapy. Chem Biol Interact 111-112 (1998) 263-275
-
(1998)
Chem Biol Interact
, vol.111-112
, pp. 263-275
-
-
Chen, X.1
Carystinos, G.D.2
Batist, G.3
-
145
-
-
14844293843
-
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study
-
Mukherjee A., Westwell A.D., Bradshaw T.D., Stevens M.F., Carmichael J., and Martin S.G. Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study. Br J Cancer 92 (2005) 350-358
-
(2005)
Br J Cancer
, vol.92
, pp. 350-358
-
-
Mukherjee, A.1
Westwell, A.D.2
Bradshaw, T.D.3
Stevens, M.F.4
Carmichael, J.5
Martin, S.G.6
-
146
-
-
0032760588
-
Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake
-
Jiang C., Jiang W., Ip C., Ganther H., and Lu J. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 26 (1999) 213-225
-
(1999)
Mol Carcinog
, vol.26
, pp. 213-225
-
-
Jiang, C.1
Jiang, W.2
Ip, C.3
Ganther, H.4
Lu, J.5
-
147
-
-
0035679739
-
Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects
-
Lu J., and Jiang C. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects. Nutr Cancer 40 (2001) 64-73
-
(2001)
Nutr Cancer
, vol.40
, pp. 64-73
-
-
Lu, J.1
Jiang, C.2
-
148
-
-
12744261583
-
Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor
-
Streicher K.L., Sylte M.J., Johnson S.E., and Sordillo L.M. Thioredoxin reductase regulates angiogenesis by increasing endothelial cell-derived vascular endothelial growth factor. Nutr Cancer 50 (2004) 221-231
-
(2004)
Nutr Cancer
, vol.50
, pp. 221-231
-
-
Streicher, K.L.1
Sylte, M.J.2
Johnson, S.E.3
Sordillo, L.M.4
-
149
-
-
27744567309
-
Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment
-
Lu da Y., Chen X.L., and Ding J. Individualized cancer chemotherapy integrating drug sensitivity tests, pathological profile analysis and computational coordination-an effective strategy to improve clinical treatment. Med Hypotheses 66 (2006) 45-51
-
(2006)
Med Hypotheses
, vol.66
, pp. 45-51
-
-
Lu da, Y.1
Chen, X.L.2
Ding, J.3
-
151
-
-
3042655539
-
Cell-type-specific responses to chemotherapeutics in breast cancer
-
Troester M.A., Hoadley K.A., Sorlie T., Herbert B.S., Borresen-Dale A.L., Lonning P.E., et al. Cell-type-specific responses to chemotherapeutics in breast cancer. Cancer Res 64 (2004) 4218-4226
-
(2004)
Cancer Res
, vol.64
, pp. 4218-4226
-
-
Troester, M.A.1
Hoadley, K.A.2
Sorlie, T.3
Herbert, B.S.4
Borresen-Dale, A.L.5
Lonning, P.E.6
-
152
-
-
27644554590
-
Individualised cancer therapeutics: dream or reality? Therapeutics construction
-
Shen Y., Senzer N., and Nemunaitis J. Individualised cancer therapeutics: dream or reality? Therapeutics construction. Expert Opin Biol Ther 5 (2005) 1427-1441
-
(2005)
Expert Opin Biol Ther
, vol.5
, pp. 1427-1441
-
-
Shen, Y.1
Senzer, N.2
Nemunaitis, J.3
-
153
-
-
0030873554
-
Schirmer RH and Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase
-
Gromer S. Schirmer RH and Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett 412 (1997) 318-320
-
(1997)
FEBS Lett
, vol.412
, pp. 318-320
-
-
Gromer, S.1
-
154
-
-
15944361817
-
Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity
-
Ronconi L., Giovagnini L., Marzano C., Bettio F., Graziani R., Pilloni G., et al. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity. Inorg Chem 44 (2005) 1867-1881
-
(2005)
Inorg Chem
, vol.44
, pp. 1867-1881
-
-
Ronconi, L.1
Giovagnini, L.2
Marzano, C.3
Bettio, F.4
Graziani, R.5
Pilloni, G.6
-
155
-
-
11344263608
-
Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma
-
Belani C.P. Recent updates in the clinical use of platinum compounds for the treatment of lung, breast, and genitourinary tumors and myeloma. Semin Oncol 31 (2004) 25-33
-
(2004)
Semin Oncol
, vol.31
, pp. 25-33
-
-
Belani, C.P.1
-
156
-
-
4544383470
-
Curcumin impairs tumor suppressor p53 function in colon cancer cells
-
Moos P.J., Edes K., Mullally J.E., and Fitzpatrick F.A. Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25 (2004) 1611-1617
-
(2004)
Carcinogenesis
, vol.25
, pp. 1611-1617
-
-
Moos, P.J.1
Edes, K.2
Mullally, J.E.3
Fitzpatrick, F.A.4
-
157
-
-
0037102391
-
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points
-
Mehta M.P., Shapiro W.R., Glantz M.J., Patchell R.A., Weitzner M.A., Meyers C.A., et al. Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points. J Clin Oncol 20 (2002) 3445-3453
-
(2002)
J Clin Oncol
, vol.20
, pp. 3445-3453
-
-
Mehta, M.P.1
Shapiro, W.R.2
Glantz, M.J.3
Patchell, R.A.4
Weitzner, M.A.5
Meyers, C.A.6
-
158
-
-
3042787102
-
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial
-
Meyers C.A., Smith J.A., Bezjak A., Mehta M.P., Liebmann J., Illidge T., et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22 (2004) 157-165
-
(2004)
J Clin Oncol
, vol.22
, pp. 157-165
-
-
Meyers, C.A.1
Smith, J.A.2
Bezjak, A.3
Mehta, M.P.4
Liebmann, J.5
Illidge, T.6
-
159
-
-
0030013113
-
Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI
-
Young S.W., Qing F., Harriman A., Sessler J.L., Dow W.C., Mody T.D., et al. Gadolinium(III) texaphyrin: a tumor selective radiation sensitizer that is detectable by MRI. Proc Natl Acad Sci USA 93 (1996) 6610-6615
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 6610-6615
-
-
Young, S.W.1
Qing, F.2
Harriman, A.3
Sessler, J.L.4
Dow, W.C.5
Mody, T.D.6
-
160
-
-
2942700238
-
Natural product based inhibitors of the thioredoxin-thioredoxin reductase system
-
Wipf P., Lynch S.M., Birmingham A., Tamayo G., Jimenez A., Campos N., et al. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system. Org Biomol Chem 2 (2004) 1651-1658
-
(2004)
Org Biomol Chem
, vol.2
, pp. 1651-1658
-
-
Wipf, P.1
Lynch, S.M.2
Birmingham, A.3
Tamayo, G.4
Jimenez, A.5
Campos, N.6
-
161
-
-
27844503452
-
Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system
-
Wipf P., Lynch S.M., Powis G., Birmingham A., and Englund E.E. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system. Org Biomol Chem 3 (2005) 3880-3882
-
(2005)
Org Biomol Chem
, vol.3
, pp. 3880-3882
-
-
Wipf, P.1
Lynch, S.M.2
Powis, G.3
Birmingham, A.4
Englund, E.E.5
-
162
-
-
0037811713
-
Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro
-
Ma S., Caprioli R.M., Hill K.E., and Burk R.F. Loss of selenium from selenoproteins: conversion of selenocysteine to dehydroalanine in vitro. J Am Soc Mass Spectrom 14 (2003) 593-600
-
(2003)
J Am Soc Mass Spectrom
, vol.14
, pp. 593-600
-
-
Ma, S.1
Caprioli, R.M.2
Hill, K.E.3
Burk, R.F.4
-
163
-
-
0035152383
-
Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates
-
Rooseboom M., Commandeur J.N., Floor G.C., Rettie A.E., and Vermeulen N.P. Selenoxidation by flavin-containing monooxygenases as a novel pathway for beta-elimination of selenocysteine Se-conjugates. Chem Res Toxicol 14 (2001) 127-134
-
(2001)
Chem Res Toxicol
, vol.14
, pp. 127-134
-
-
Rooseboom, M.1
Commandeur, J.N.2
Floor, G.C.3
Rettie, A.E.4
Vermeulen, N.P.5
-
165
-
-
0035890009
-
Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex
-
Arnér E.S., Nakamura H., Sasada T., Yodoi J., Holmgren A., and Spyrou G. Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cis-diamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex. Free Radic Biol Med 31 (2001) 1170-1178
-
(2001)
Free Radic Biol Med
, vol.31
, pp. 1170-1178
-
-
Arnér, E.S.1
Nakamura, H.2
Sasada, T.3
Yodoi, J.4
Holmgren, A.5
Spyrou, G.6
-
166
-
-
0026541177
-
Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck
-
Holding J.D., Lindup W.E., van Laer C., Vreeburg G.C., Schilling V., Wilson J.A., et al. Phase I trial of a cisplatin-albumin complex for the treatment of cancer of the head and neck. Br J Clin Pharmacol 33 (1992) 75-81
-
(1992)
Br J Clin Pharmacol
, vol.33
, pp. 75-81
-
-
Holding, J.D.1
Lindup, W.E.2
van Laer, C.3
Vreeburg, G.C.4
Schilling, V.5
Wilson, J.A.6
-
167
-
-
4644244279
-
Medicine. Targeting apoptotic pathways in cancer cells
-
Denicourt C., and Dowdy S.F. Medicine. Targeting apoptotic pathways in cancer cells. Science 305 (2004) 1411-1413
-
(2004)
Science
, vol.305
, pp. 1411-1413
-
-
Denicourt, C.1
Dowdy, S.F.2
-
168
-
-
0037013154
-
A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
-
Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., et al. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109 (2002) 335-346
-
(2002)
Cell
, vol.109
, pp. 335-346
-
-
Schmitt, C.A.1
Fridman, J.S.2
Yang, M.3
Lee, S.4
Baranov, E.5
Hoffman, R.M.6
-
169
-
-
0034945142
-
Dissection the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer drugs
-
Ruefli A.A., Davis J.E., Sutten V.R., Trapani J.A., Smyth M.J., and Johnstone R.W. Dissection the apoptotic mechanisms of chemotherapeutic drugs and lymphocytes to design effective anticancer drugs. Drug Dev Res 52 (2001) 549-557
-
(2001)
Drug Dev Res
, vol.52
, pp. 549-557
-
-
Ruefli, A.A.1
Davis, J.E.2
Sutten, V.R.3
Trapani, J.A.4
Smyth, M.J.5
Johnstone, R.W.6
|